Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

NCT03518242 PHASE1 COMPLETED

This phase I trial studies the molecular profile of breast cancer in Ugandan patients with stage IIB-III breast cancer. Creating a molecular profile of breast cancer my help doctors learn more about biological factors associated with breast cancer in Ugandan patients with as well as measure the benefits of locally available diagnostic studies and the possibility of providing treatment via oral medication.

Details

Lead sponsor	Fred Hutchinson Cancer Center
Phase	PHASE1
Status	COMPLETED
Enrolment	100
Start date	Wed Jun 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed May 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Breast Cancer Female
• Anatomic Stage IIB Breast Cancer AJCC v8
• Anatomic Stage III Breast Cancer AJCC v8
• Anatomic Stage IIIA Breast Cancer AJCC v8
• Anatomic Stage IIIB Breast Cancer AJCC v8
• Anatomic Stage IIIC Breast Cancer AJCC v8
• Invasive Breast Carcinoma
• Prognostic Stage IIB Breast Cancer AJCC v8
• Prognostic Stage III Breast Cancer AJCC v8
• Prognostic Stage IIIA Breast Cancer AJCC v8

Interventions

• Cyclophosphamide
• Methotrexate
• Capecitabine
• Biospecimen Collection

Countries

Uganda